Best Kinase Inhibitor for leukemia, myeloid
Top-rated pick: Sprycel — pharmaranks score 72/100, the highest of the 5 Kinase Inhibitor drugs used for leukemia, myeloid, ranked by our independent FDA recall-safety score. Compare them with all treatments for leukemia, myeloid or the full Kinase Inhibitor class. Not medical advice — always consult a professional.
Quick answer: Of the 5 kinase inhibitor drugs we rate for leukemia, myeloid, 4 are available as lower-cost generics, and most are tablet. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for leukemia, myeloid; the right choice depends on your situation, so confirm it with your prescriber.
How kinase inhibitor work
Kinase inhibitors block protein kinases, the enzymes that relay 'grow and divide' signals inside cells. By shutting down the overactive kinase signals that a tumor depends on, they help slow or stop cancer cells from multiplying.
Source: Tyrosine Kinase Inhibitors - StatPearls - NCBI Bookshelf
Top kinase inhibitor for leukemia, myeloid: 1. Sprycel · 2. Gleevec · 3. Iclusig
| # | Drug | Rating | Type | Form | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Tablet | Generic | $839 | View → | |
| 2 | 70/100 | Prescription | Tablet | Generic | $26 | View → | |
| 3 | Not yet rated | Prescription | Tablet | No data | — | View → | |
| 4 | Not yet rated | Prescription | Solution | Generic | $26 | View → | |
| 5 | Not yet rated | Prescription | Tablet | Generic | $839 | View → |
Full ranking · 5 drugs
sprycel
PrescriptionFDA-sourced
Sprycel (Dasatinib) is a kinase inhibitor used to treat Lymphoid Leukemia, Myeloid Leukemia.
Pharmacy pays
~$839.19 /30
Save up to 97% in class
gleevec
PrescriptionFDA-sourced
Gleevec (Imatinib Mesylate) is a kinase inhibitor used to treat Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome, Dermatofibrosarcoma.
Pharmacy pays
From ~$23.82/30· 2 forms
iclusig
Boxed warningPrescriptionFDA-sourced
Iclusig (Ponatinib Hydrochloride) is a kinase inhibitor used to treat Myeloid Leukemia.
Price varies
imkeldi
PrescriptionFDA-sourced
Imkeldi (Imatinib Mesylate) is a kinase inhibitor used to treat Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome, Dermatofibrosarcoma.
Pharmacy pays
From ~$23.82/30· 2 formsphyrago
PrescriptionFDA-sourced
Phyrago (Dasatinib) is a kinase inhibitor used to treat Lymphoid Leukemia, Myeloid Leukemia.
Pharmacy pays
~$839.19 /30
Save up to 97% in classFrequently asked
- What is the best kinase inhibitor for leukemia, myeloid?
- By our independent recall-safety rating — not an efficacy measure — sprycel ranks highest among Kinase Inhibitor drugs used for leukemia, myeloid. Always consult a professional.
- Which kinase inhibitor drugs treat leukemia, myeloid?
- pharmaranks lists 5 Kinase Inhibitor products used for leukemia, myeloid, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.